Chem Rx Corp Revenue and Competitors
Estimated Revenue & Valuation
- Chem Rx Corp's estimated annual revenue is currently $30.4M per year.
- Chem Rx Corp's estimated revenue per employee is $201,000
Employee Data
- Chem Rx Corp has 151 Employees.
Chem Rx Corp Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $12.3M | 61 | 7% | N/A | N/A |
#2 | $354.3M | 461 | -2% | $567.1M | N/A |
#3 | $377.1M | 1876 | -1% | N/A | N/A |
#4 | $7.8M | 39 | 8% | N/A | N/A |
#5 | $5.4M | 27 | 0% | N/A | N/A |
#6 | $45M | 224 | 6% | N/A | N/A |
#7 | $6.8M | 34 | -82% | N/A | N/A |
#8 | $9.2M | 46 | 12% | N/A | N/A |
#9 | N/A | 694 | 46% | N/A | N/A |
#10 | $15.5M | 77 | 5% | N/A | N/A |
What Is Chem Rx Corp?
"CHEM Rx can optimize profitability of target companies with its depth of management, leading edge technology, strong financial resources and tremendous buying power, thereby further leveraging our leadership position," said Jerry Silva. "What differentiates CHEM Rx from our bigger competitors is that we will always put our customer's needs first," added Silva. Founded over forty years ago, CHEM Rx is the largest privately owned and third largest long-term care pharmacy in the nation.
keywords:N/A
N/A
Total Funding
151
Number of Employees
$30.4M
Revenue (est)
N/A
Employee Growth %
N/A
Valuation
N/A
Accelerator
Chem Rx Corp News
... Optum Rx Inc., Rowlands Pharmacy, The Kroger Co., Walgreen Co., ... physical and chemical growth methodologies employed by companies in...
Deltech LLC, Dow, RX Chemicals, Zhengdan Chemical, Hangzhou Colorific ... and data necessary to achieve corporate goals and critical revenue decisions.
(US), BASF SE (Germany), Mitsubishi Chemical Corporation (Japan), Toagosei Co., ... RX MARINE INTERNATIONAL (India), Vizag Chemical (India),...
Other Companies in Long Beach
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $45.1M | 152 | -4% | N/A |
#2 | $40.2M | 153 | -7% | N/A |
#3 | $45.5M | 156 | 21% | N/A |
#4 | $26.7M | 162 | 22% | N/A |
#5 | $28.7M | 163 | 9% | N/A |